Gastrointestinal motility and secretion: peristalsis, gastric acid, enzymes, and absorption sites

Intuition Beginner

Food moves through the digestive tract by peristalsis -- waves of circular muscle contraction that push food along the tube. Each wave squeezes the segment of gut just behind the food bolus while relaxing the segment just ahead of it, propelling the contents forward. Peristalsis operates from the esophagus all the way to the large intestine, and it works even in a detached segment of gut because the enteric nervous system controls it locally.

The stomach produces a powerful acid, hydrochloric acid (HCl), with a pH of about 2. This acid has two jobs: it denatures proteins (unfolding them so enzymes can access peptide bonds) and it kills most bacteria and pathogens swallowed with food. The stomach lining protects itself from this acid with a thick layer of mucus and by secreting bicarbonate at the cell surface.

The pancreas adds enzymes that digest proteins (trypsin, chymotrypsin), fats (lipase), and carbohydrates (amylase). It also secretes bicarbonate to neutralise the acidic chyme arriving from the stomach. The liver contributes bile, which emulsifies fats into small droplets that lipase can attack.

Most nutrient absorption happens in the small intestine, whose inner surface is folded into tiny finger-like projections called villi. Each villus is covered with even smaller microvilli, giving the small intestine an absorptive surface area of roughly 250 square metres. Capillaries inside each villus carry absorbed sugars and amino acids into the bloodstream, while a lymphatic vessel (the lacteal) carries absorbed fats.

Visual Beginner

Region	Motility pattern	Key secretions	Primary absorption
Mouth	Chewing (mastication)	Salivary amylase, mucus	Minimal (some drugs sublingual)
Esophagus	Peristalsis	Mucus	None
Stomach	Mixing waves (3 per min)	HCl, pepsin, mucus, intrinsic factor	Water, alcohol, some drugs
Duodenum	Segmentation + peristalsis	Bile, pancreatic juice, bicarbonate	Iron, calcium
Jejunum	Segmentation + peristalsis	Brush-border enzymes	Carbohydrates, protein, folate
Ileum	Segmentation + peristalsis	--	Vitamin B12, bile salts
Large intestine	Haustral churn, mass movements	Mucus	Water, electrolytes

Worked example Beginner

Trace the path of a swallowed bolus from the esophagus to the small intestine, naming the motility pattern and secretions at each stage.

Step 1. Esophagus. The upper esophageal sphincter relaxes and the bolus enters the esophagus. A peristaltic wave -- contraction of circular muscle behind the bolus with relaxation ahead of it -- pushes the bolus toward the stomach in about 5-8 seconds. The lower esophageal sphincter relaxes to let the bolus pass, then contracts to prevent reflux.

Step 2. Stomach. The stomach produces mixing waves (about 3 per minute) that churn the bolus with gastric secretions (HCl, pepsin) to form a semi-liquid paste called chyme. The stomach empties chyme into the duodenum slowly -- a typical meal takes 2-4 hours to leave the stomach. Liquids empty faster than solids; fats empty slowest.

Step 3. Duodenum. Chyme entering the duodenum triggers the release of secretin (stimulating pancreatic bicarbonate) and CCK (stimulating pancreatic enzymes and gallbladder contraction). Bile emulsifies fats; pancreatic enzymes digest all three macronutrient classes. Segmentation contractions mix chyme with digestive secretions without propelling it far downstream.

Step 4. Jejunum and ileum. Segmentation continues. Brush-border enzymes (lactase, sucrase, maltase, peptidases) complete digestion at the epithelial surface. The products -- monosaccharides, amino acids, fatty acids -- are absorbed across the epithelium into capillaries or lacteals.

Check your understanding Beginner

Formal definition Intermediate+

Motility patterns

Peristalsis and the law of the intestine. Bayliss and Starling (1899) described the "law of the intestine" (also called the myenteric reflex): distension of a segment of gut triggers contraction of circular muscle oral (proximal) to the bolus and relaxation aboral (distal) to it. This reflex is mediated entirely by the enteric nervous system and persists after severing all extrinsic nerves. The myenteric plexus integrates sensory input from stretch receptors and chemoreceptors in the mucosa to coordinate the peristaltic wave.

Segmentation. Ring-like contractions of the circular smooth muscle that divide the small intestine into segments of approximately 1-2 cm. Segmentation frequency decreases along the GI tract: approximately 12 per minute in the duodenum, 9 per minute in the jejunum, and 6 per minute in the ileum. This gradient creates a slow net aboral flow. Segmentation is initiated by the slow waves (basic electrical rhythm) generated by the interstitial cells of Cajal, which serve as pacemakers for gut smooth muscle.

Migrating motor complex (MMC). During the interdigestive (fasting) state, a cyclical pattern of motility sweeps through the stomach and small intestine every 90-120 minutes. The MMC has three phases: Phase I (quiescence, no contractions), Phase II (irregular contractions of increasing amplitude), and Phase III (a burst of intense peristaltic contractions that sweep the entire small intestine, clearing residual debris, desquamated cells, and bacteria toward the colon). Motilin, released from M cells in the duodenum during fasting, initiates Phase III. Feeding interrupts the MMC and replaces it with segmentation and fed-state peristalsis.

Swallowing phases. Deglutition involves three phases. The oral phase (voluntary) pushes the bolus into the oropharynx with the tongue. The pharyngeal phase (involuntary, mediated by the swallowing centre in the medulla) coordinates: the soft palate elevates to seal the nasopharynx, the larynx elevates and the epiglottis covers the glottis, the upper esophageal sphincter relaxes, and peristalsis propels the bolus through the pharynx. The esophageal phase (involuntary) uses primary peristalsis (driven by vagal input) and secondary peristalsis (driven by local enteric reflexes if the bolus remains) to deliver the bolus to the stomach.

Gastric acid secretion

Parietal cells in the gastric glands secrete HCl at a concentration of approximately 160 mM (pH ~0.8). Three secretagogues stimulate parietal cells, acting synergistically:

1. Acetylcholine (from vagal parasympathetic fibres) binds M3 muscarinic receptors, increasing intracellular Ca2+ and stimulating acid secretion.

2. Histamine (from enterochromaffin-like [ECL] cells) binds H2 receptors, activating adenylate cyclase and raising intracellular cAMP. The histamine-cAMP pathway is the dominant amplifier of acid secretion.

3. Gastrin (from G cells in the gastric antrum) binds CCK-B receptors on parietal cells (stimulating acid directly) and on ECL cells (stimulating histamine release, which amplifies acid secretion indirectly).

The parietal cell's apical membrane contains the H+/K+ ATPase (the proton pump), which exchanges intracellular H+ for luminal K+ at a 1:1 ratio, consuming ATP. Carbonic anhydrase within the parietal cell catalyses CO2 + H2O to H2CO3, which dissociates into H+ (pumped out) and HCO3- (exited basolaterally via the Cl-/HCO3- exchanger). This generates the "alkaline tide" -- a transient rise in blood pH and urinary bicarbonate after a meal.

Regulation by phase. The cephalic phase (sight, smell, thought of food; vagal pathways) accounts for approximately 30% of acid secretion. The gastric phase (distension, peptides in the stomach) accounts for approximately 60%. The intestinal phase (partially digested nutrients in the duodenum) accounts for approximately 10% and is dominated by inhibitory feedback.

Somatostatin inhibition. D cells in the gastric antrum and corpus secrete somatostatin, which inhibits gastrin release from G cells (paracrine), histamine release from ECL cells, and acid secretion from parietal cells. Somatostatin secretion is stimulated by low antral pH (providing negative feedback: as acid accumulates, somatostatin rises and shuts down further secretion) and by CCK and secretin.

Pancreatic secretion

The pancreas secretes 1-2 litres per day of juice containing two classes of product:

Bicarbonate secretion (from ductal and centroacinar cells) is stimulated by secretin (released from duodenal S cells when acidic chyme arrives). Secretin activates cAMP in duct cells, opening the CFTR chloride channel; chloride is then exchanged for bicarbonate via the apical Cl-/HCO3- exchanger. Pancreatic bicarbonate raises duodenal pH from ~2 to ~7-8, providing the optimal environment for pancreatic enzymes.

Enzyme secretion (from acinar cells) is stimulated by CCK (released from duodenal I cells by fats and amino acids) and by acetylcholine (from vagovagal reflexes). Enzymes include: amylase (starch to oligosaccharides), lipase and colipase (triglycerides to fatty acids and monoglycerides), trypsinogen/chymotrypsinogen/procarboxypeptidase (protein zymogens activated in the duodenum), and nucleases.

Bile

Hepatocytes produce 600-1000 mL of bile per day. Between meals, bile is diverted to the gallbladder for storage and concentration (water and electrolyte reabsorption concentrates bile 5-10 fold). CCK, released by fats and amino acids in the duodenum, causes gallbladder contraction and relaxation of the sphincter of Oddi, delivering concentrated bile into the duodenum. Bile salts emulsify triglycerides into micelles, increasing the surface area for lipase. Bile salts are reabsorbed in the terminal ileum via the apical sodium-dependent bile acid transporter (ASBT) and recycled via the enterohepatic circulation (see 18.06.01).

Brush-border enzymes and absorption sites

The apical surface of enterocytes carries enzymes that complete digestion at the epithelial surface:

• Lactase hydrolyses lactose to glucose + galactose
• Sucrase hydrolyses sucrose to glucose + fructose
• Maltase-glucoamylase hydrolyses maltose and maltotriose to glucose
• Aminopeptidases and dipeptidases cleave small peptides to amino acids

Absorption sites along the GI tract have regional specialisation:

Region	Key absorptive function	Transport mechanism
Duodenum	Iron (Fe2+ via DMT1), calcium (Ca2+ via TRPV6, calbindin)	Active transport
Jejunum	Glucose (SGLT1), galactose (SGLT1), fructose (GLUT5), amino acids (Na+-dependent cotransporters), folate	Active + facilitated
Ileum	Vitamin B12 (with intrinsic factor, via cubilin receptor), bile salts (via ASBT), vitamin C	Receptor-mediated endocytosis (B12), active transport

Key experiment Intermediate+

Bayliss and Starling (1899) -- the law of the intestine.

William Bayliss and Ernest Starling isolated a segment of dog small intestine with all extrinsic nerves severed. When they distended a point in the lumen, they observed contraction of circular muscle oral to the point of stimulation and relaxation aboral to it -- a peristaltic wave that moved the content forward. Because extrinsic innervation had been cut, the reflex had to be entirely intrinsic to the gut wall. This experiment demonstrated that the enteric nervous system can generate coordinated motility independently of the central nervous system.

Proposition (The law of the intestine / myenteric reflex). Luminal distension triggers an orad contraction and aborad relaxation of circular smooth muscle via an intrinsic reflex mediated by the myenteric plexus, producing net aboral propulsion of luminal contents. The reflex persists after section of all extrinsic nerves.

Derivation. Luminal distension activates mechanosensitive neurons in the submucosal plexus, which send excitatory signals orally to cholinergic motor neurons in the myenteric plexus. These motor neurons release acetylcholine and substance P onto circular smooth muscle, causing contraction. Simultaneously, inhibitory motor neurons release nitric oxide (NO) and vasoactive intestinal peptide (VIP) onto circular smooth muscle aboral to the site of distension, causing relaxation. The pressure gradient between the contracted (high-pressure) orad segment and the relaxed (low-pressure) aborad segment drives the bolus forward. The reflex arc is entirely contained within the enteric nervous system (sensory neuron -> interneuron -> motor neuron), requiring no input from the brain or spinal cord. $\square$

Bridge. This intrinsic reflex is the foundation of all gut motility. When the myenteric plexus is damaged (as in Hirschsprung disease, where neural crest cells fail to colonise a segment of distal colon, producing an aganglionic segment), the peristaltic wave cannot propagate through the affected region, causing functional obstruction and massive distension of the proximal colon. In Chagas disease (Trypanosoma cruzi infection), destruction of myenteric neurons produces achalasia (failure of lower esophageal sphincter relaxation) and megacolon by the same mechanism.

Exercises Intermediate+

Advanced treatment Master

Peptic ulcer disease

Peptic ulcers are breaks in the mucosal surface of the stomach (gastric ulcers) or duodenum (duodenal ulcers) extending through the muscularis mucosae. Two aetiologies account for the vast majority of cases.

Helicobacter pylori. Barry Marshall and Robin Warren demonstrated in 1984 that H. pylori colonisation of the gastric mucosa causes chronic gastritis and is the principal cause of peptic ulcer disease (accounting for approximately 70% of gastric ulcers and 90% of duodenal ulcers). H. pylori produces urease, which generates ammonia to buffer the local acidic environment, allowing the bacterium to survive in the stomach. It also produces cytotoxins (CagA, VacA) that damage epithelial cells and provoke an inflammatory response. The resulting chronic gastritis disrupts the normal regulation of acid secretion: in antrum-predominant gastritis, H. pylori suppresses somatostatin-producing D cells, removing the brake on gastrin secretion and producing a hypergastrinaemic state with increased acid output. The excess acid overwhelms duodenal mucosal defences, causing duodenal ulcers. Eradication of H. pylori with triple therapy (PPI + clarithromycin + amoxicillin or metronidazole) cures the ulcer diathesis and prevents recurrence.

NSAID-induced ulcers. Nonsteroidal anti-inflammatory drugs (aspirin, ibuprofen, naproxen) inhibit cyclooxygenase-1 (COX-1), the enzyme that produces prostaglandins (PGE2, PGI2) in the gastric mucosa. These prostaglandins stimulate mucus and bicarbonate secretion, maintain mucosal blood flow, and suppress acid secretion. When COX-1 is inhibited, mucosal defence is weakened: mucus and bicarbonate production fall, mucosal blood flow decreases, and the epithelium becomes vulnerable to acid injury. NSAIDs also have direct topical irritant effects (weak acids that accumulate in gastric epithelial cells). COX-2 selective NSAIDs (celecoxib) spare gastric COX-1 and reduce ulcer risk, but carry increased cardiovascular risk.

Gastroesophageal reflux disease (GERD)

GERD results from chronic reflux of gastric contents into the esophagus, causing symptoms (heartburn, regurgitation) and potentially complications (esophagitis, stricture, Barrett's esophagus, adenocarcinoma). The primary mechanism is incompetence of the lower esophageal sphincter (LES): transient LES relaxations (TLESRs) -- vagally mediated relaxations not triggered by swallowing -- are the dominant mechanism in most patients, allowing acid to flow retrograde. Contributing factors include reduced LES pressure, hiatal hernia (which disrupts the gastroesophageal junction), delayed gastric emptying, and increased intra-abdominal pressure (obesity, pregnancy). Treatment ranges from lifestyle modifications to PPIs to fundoplication (surgical reinforcement of the LES by wrapping the gastric fundus around the distal esophagus).

Celiac disease

Celiac disease is an autoimmune enteropathy triggered by ingestion of gluten (specifically gliadin peptides from wheat, and homologous proteins from barley and rye) in genetically susceptible individuals carrying HLA-DQ2 or HLA-DQ8. Deamidated gliadin peptides are presented by DQ2/DQ8 on antigen-presenting cells, activating CD4+ T cells in the lamina propria. These T cells release IFN-gamma and other inflammatory cytokines, driving villous atrophy, crypt hyperplasia, and intraepithelial lymphocytosis. The result is loss of absorptive surface area: flattened villi, decreased disaccharidase activity (producing secondary lactose intolerance), and malabsorption of iron, folate, calcium, and fat-soluble vitamins. Diagnosis requires duodenal biopsy showing Marsh stage 3 changes (villous atrophy) and positive serology (anti-tissue transglutaminase IgA). Treatment is a lifelong gluten-free diet.

Lactose intolerance

Lactase non-persistence (adult-type hypolactasia) is the most common enzyme deficiency worldwide. Lactase activity declines after weaning in approximately 65-70% of the global population (the normative state; lactase persistence in northern European and some African pastoralist populations is the derived trait, associated with a C/T polymorphism at -13910 upstream of the lactase gene). Undigested lactose in the small intestinal lumen increases osmotic load, drawing water into the lumen (osmotic diarrhoea). In the colon, bacteria ferment lactose to short-chain fatty acids and gases (H2, CO2, CH4), producing bloating, flatulence, and cramping. Diagnosis is by hydrogen breath test (oral lactose load, measure exhaled H2). Treatment is dietary lactose avoidance or lactase enzyme supplementation.

Pancreatic insufficiency

Exocrine pancreatic insufficiency (EPI) occurs when pancreatic enzyme secretion falls below 10% of normal, producing malabsorption. Causes include chronic pancreatitis (the most common cause in adults, typically from alcohol), cystic fibrosis (the most common cause in children, where thick secretions obstruct pancreatic ducts), and pancreatic resection. Steatorrhea (fatty stools, >7g fat/day) is the hallmark: without adequate lipase and colipase, dietary triglycerides cannot be digested and absorbed. Fat-soluble vitamins (A, D, E, K) are also malabsorbed. Treatment is pancreatic enzyme replacement therapy (PERT) with enteric-coated microspheres containing lipase, amylase, and protease, taken with meals.

Small intestinal bacterial overgrowth (SIBO)

SIBO is defined as greater than 10^5 colony-forming units per mL of proximal jejunal aspirate (normal: less than 10^3 CFU/mL). The small intestine is normally kept relatively sterile by gastric acid, the MMC, bile, and the ileocecal valve. When these protective mechanisms fail (achlorhydria, impaired motility as in diabetic autonomic neuropathy or scleroderma, structural abnormalities like blind loops or strictures), colonic-type bacteria colonise the small intestine. These bacteria deconjugate bile salts (reducing fat absorption), consume nutrients (producing bloating and gas), and damage the mucosal brush border (causing secondary carbohydrate and protein malabsorption). Diagnosis is by hydrogen breath test (glucose or lactulose substrate) or quantitative jejunal culture. Treatment addresses the underlying cause and uses targeted antibiotics (rifaximin).

Short bowel syndrome

Short bowel syndrome results from surgical resection of more than 50% of the small intestine (causes: Crohn's disease, mesenteric infarction, volvulus, trauma). The severity depends on which segments remain: the duodenum and proximal jejunum are responsible for most nutrient absorption, while the terminal ileum absorbs B12 and bile salts. Loss of the ileum is particularly problematic because it disrupts the enterohepatic circulation of bile acids, leading to bile acid deficiency, fat malabsorption, and oxalate kidney stones (increased colonic absorption of dietary oxalate, which normally binds calcium but now binds fatty acids instead). Patients require parenteral nutrition initially, with gradual transition to enteral feeding as the remaining intestine adapts (intestinal adaptation: villous hypertrophy, increased absorptive surface area, upregulated transporter expression over weeks to months). GLP-2 (teduglutide) promotes intestinal adaptation and reduces parenteral nutrition requirements.

GI hormones beyond the classic five

The GI tract is the largest endocrine organ in the body. Beyond gastrin, secretin, CCK, GIP, and GLP-1, several additional hormones have significant physiological and clinical roles:

Ghrelin is produced by X/A-like cells in the gastric fundus and is the only known circulating orexigenic (appetite-stimulating) hormone. Ghrelin rises before meals and falls after eating, acting on the arcuate nucleus of the hypothalamus to stimulate food intake. Ghrelin also stimulates growth hormone secretion and gastric motility. In practical terms, ghrelin is the "hunger hormone."

GIP (glucose-dependent insulinotropic polypeptide, also called gastric inhibitory peptide) is released from K cells in the duodenum by glucose and fats. It amplifies glucose-stimulated insulin secretion (the incretin effect, shared with GLP-1). Unlike GLP-1, GIP does not suppress glucagon or slow gastric emptying. In type 2 diabetes, the insulinotropic effect of GIP is diminished, while GLP-1's effect is relatively preserved.

GLP-1 (glucagon-like peptide-1) is produced by L cells in the ileum and colon. Beyond its incretin effect (amplifying insulin secretion), GLP-1 suppresses glucagon, slows gastric emptying, and reduces appetite via hypothalamic and brainstem receptors. GLP-1 receptor agonists (semaglutide, tirzepatide) exploit these pleiotropic effects to treat type 2 diabetes and obesity.

PYY (peptide YY) is released from L cells in the ileum and colon in response to nutrients, particularly fats. PYY acts on Y2 receptors in the hypothalamus to reduce appetite and slows gastrointestinal transit (the "ileal brake"), providing feedback that limits further food intake and slows delivery of nutrients to the colon.

The gut-brain axis

The gut-brain axis is a bidirectional communication network linking the enteric nervous system, the central nervous system, and the endocrine and immune systems. Three pathways mediate this communication:

1. Neural. The vagus nerve carries approximately 80% afferent (gut-to-brain) and 20% efferent (brain-to-gut) fibres. Vagal afferents are activated by mechanical stretch, chemical stimuli, and gut hormones (CCK, GLP-1, PYY), relaying information about nutrient intake to the nucleus of the solitary tract in the brainstem. Vagal efferents modulate gastric motility, secretion, and mucosal immune function.

2. Endocrine. Gut hormones (ghrelin, GLP-1, PYY, GIP, CCK) act on hypothalamic and brainstem nuclei that regulate appetite, satiety, and energy balance. The serotonergic system is a major component: approximately 95% of the body's serotonin is produced by enterochromaffin cells in the GI tract, where it regulates motility, secretion, and visceral pain signalling.

3. Immune and microbial. Gut bacteria produce neurotransmitters (GABA, serotonin, dopamine), short-chain fatty acids, and other metabolites that influence brain function. The microbiome modulates the hypothalamic-pituitary-adrenal (HPA) axis stress response. Germ-free mice show exaggerated HPA responses to stress that are normalised by colonisation with specific bacterial species. In humans, associations between dysbiosis and anxiety, depression, and irritable bowel syndrome have been demonstrated, though causality remains under investigation.

Motility disorders

Gastroparesis is delayed gastric emptying without mechanical obstruction. The most common causes are diabetes (autonomic neuropathy damaging vagal fibres and ICCs), post-surgical (vagotomy), and idiopathic. Symptoms include nausea, vomiting, early satiety, bloating, and postprandial fullness. Diagnosis is by gastric emptying scintigraphy (retention of greater than 10% of a solid meal at 4 hours). Treatment includes dietary modification (small, frequent, low-fat, low-fibre meals), prokinetic agents (metoclopramide, domperidone, erythromycin), and in refractory cases, gastric electrical stimulation or jejunostomy feeding.

Irritable bowel syndrome (IBS) is a functional GI disorder characterised by abdominal pain associated with altered bowel habits (diarrhoea-predominant, constipation-predominant, or mixed), in the absence of structural or biochemical abnormalities. Pathophysiology involves visceral hypersensitivity (lowered pain threshold to gut distension), altered motility, and brain-gut dysfunction. Low-grade mucosal inflammation and post-infectious mechanisms (IBS developing after acute gastroenteritis) are implicated in subsets of patients. Treatment is symptom-directed: antispasmodics, dietary modification (the low-FODMAP diet reduces fermentable oligosaccharide, disaccharide, monosaccharide, and polyol intake), and neuromodulators (low-dose tricyclics for pain).

Chronic intestinal pseudo-obstruction is a rare, severe motility disorder in which the clinical presentation mimics mechanical obstruction (abdominal pain, distension, vomiting, constipation) but no anatomical blockage exists. Causes include visceral myopathies (smooth muscle degeneration), visceral neuropathies (enteric neuronal degeneration, as in familial mitochondrial disorders or paraneoplastic syndromes), and secondary causes (scleroderma, amyloidosis, opioid use). Diagnosis requires manometry and full-thickness biopsy. Management is supportive (nutritional support, decompression, prokinetics) and often requires long-term parenteral nutrition.

Connections Master

1. 18.06.01 Digestive physiology and nutrition. The present unit deepens the motility and secretion topics introduced in 18.06.01. That unit provided the anatomical overview of the GI tract (four-layer wall structure, villi, microvilli) and the enzymatic digestion of macronutrients; this unit adds the regulatory physiology (neural and hormonal control of motility and secretion), the regional specialisation of absorption, and the clinical consequences of dysregulation.

2. 17.07.01 Cell signaling -- GPCRs. The hormonal regulation of GI motility and secretion exploits GPCR signalling mechanisms. Gastrin and CCK act through CCK-B and CCK-A receptors (GPCRs), respectively. Secretin activates a Gs-coupled receptor on pancreatic duct cells. Histamine acts via the H2 Gs-coupled receptor on parietal cells. The enteric nervous system uses GPCR-mediated neurotransmission (muscarinic M3 receptors, tachykinin NK receptors). The GLP-1 and GIP incretin hormones act through Gs-coupled receptors.

3. 18.05.04 pending Autonomic nervous system. The parasympathetic (vagus) and sympathetic innervation of the GI tract modulates the enteric nervous system. Vagal parasympathetic input stimulates motility and secretion (the cephalic phase of gastric acid secretion is vagally mediated). Sympathetic input inhibits motility and secretion and constricts splanchnic blood vessels (the "fight or flight" response diverts blood from the gut to skeletal muscle).

4. 17.03.01 Cellular organization. The specialised epithelial cell types of the GI tract (parietal cells, chief cells, G cells, S cells, I cells, enterochromaffin cells, enterocytes, goblet cells) illustrate the principle that cell structure determines function. The parietal cell's extensive canalicular system, abundant mitochondria (approximately 30-40% of cell volume, reflecting the enormous ATP demand of the H+/K+ ATPase), and carbonic anhydrase-rich cytoplasm are structural adaptations for concentrated acid secretion.

5. 18.03.01 Respiratory physiology. The diaphragm, which drives pulmonary ventilation, also affects GI motility through its role in intra-abdominal pressure regulation and through the vagus nerve's dual role in respiratory and GI control. Post-operative ileus (temporary cessation of gut motility after abdominal surgery) involves sympathetic overactivity and inhibitory vagal reflexes similar to those involved in respiratory protective reflexes.

6. 18.07.01 Endocrine hormones and regulation. The GI hormones (gastrin, secretin, CCK, GIP, GLP-1, ghrelin, PYY, motilin) constitute a major endocrine system. Several of these hormones have been exploited pharmacologically: GLP-1 receptor agonists for diabetes and obesity, motilin receptor agonists for gastroparesis, and somatostatin analogues (octreotide) for hormone-secreting tumours and variceal bleeding.

Historical & philosophical context Master

The understanding of GI motility and secretion developed through a series of landmark experiments spanning more than two centuries.

William Beaumont's observations of Alexis St. Martin's gastric fistula (1825-1833) established that gastric digestion is a chemical process requiring acid, that secretion is stimulated by the sight and thought of food (the cephalic phase), and that emotional states alter gastric function. Beaumont's work, published in 1833 as Experiments and Observations on the Gastric Juice, was the first systematic study of human gastric physiology and laid the groundwork for Pavlov's later work on the nervous control of digestion.

Ivan Pavlov's Nobel Prize-winning work on digestive physiology (1904) used chronic fistula techniques in dogs to demonstrate the neural regulation of gastric and pancreatic secretion. His discovery of the conditioned reflex -- dogs secreting gastric juice in anticipation of food -- was a direct demonstration of the cephalic phase and became the foundation of behavioral psychology. Pavlov showed that the vagus nerve mediates the cephalic phase of gastric secretion and that sectioning the vagus (vagotomy) substantially reduces acid output.

The discovery of hormonal regulation of digestion by Bayliss and Starling in 1902 was a turning point. Their demonstration that acidifying the duodenum stimulated pancreatic secretion even after all nerves to the pancreas had been severed proved the existence of a chemical messenger carried by blood -- secretin, the first identified hormone. Starling coined the term "hormone" (from the Greek "to excite or set in motion") in 1905. Their 1899 work on the law of the intestine demonstrated the intrinsic reflex basis of peristalsis, establishing the enteric nervous system as a semi-autonomous control system.

The identification of gastrin by Gregory and Tracy in 1964 (isolating and sequencing the 17-amino-acid peptide from hog antral mucosa) completed the characterisation of the major GI hormones. The subsequent development of histamine H2 receptor antagonists by James Black and colleagues at Smith Kline and French (cimetidine, approved in 1976) was the first rationally designed drug targeting a specific GI receptor and transformed the treatment of peptic ulcer disease. The later development of proton pump inhibitors (omeprazole, introduced in 1989) provided even more potent acid suppression by targeting the final common pathway of acid secretion.

The discovery of H. pylori by Barry Marshall and Robin Warren in 1982-1984 overturned the prevailing view that peptic ulcers were caused by stress and acid alone. Marshall's self-experiment -- ingesting H. pylori to demonstrate that it causes gastritis -- is one of the most dramatic examples of self-experimentation in medical history. Their work, recognised with the Nobel Prize in 2005, transformed peptic ulcer disease from a chronic, relapsing condition requiring surgery or lifelong medication into a curable disease with antibiotic therapy.

The concept of the gut-brain axis has its roots in the 19th century observation that emotional states affect bowel function ("nervous diarrhoea," "butterflies in the stomach"). The formalisation of this concept has accelerated since the 1990s, driven by the recognition that the enteric nervous system contains approximately 100 million neurons and produces the full repertoire of neurotransmitters found in the CNS, that approximately 95% of the body's serotonin is produced in the gut, and that the gut microbiome produces neuroactive metabolites that influence brain function. Michael Gershon's popularisation of the enteric nervous system as the "second brain" (1998) and the explosion of microbiome research since the Human Microbiome Project (2007-2016) have made the gut-brain axis one of the most active research areas in integrative physiology.

Bibliography Master

1. Bayliss, W. M. and Starling, E. H. (1899). The movements and innervation of the small intestine. J. Physiol. 24, 99-143.

2. Pavlov, I. P. (1902). The Work of the Digestive Glands. Translated by W. H. Thompson. Charles Griffin, London.

3. Beaumont, W. (1833). Experiments and Observations on the Gastric Juice and the Physiology of Digestion. Platt and Smith, Plattsburgh.

4. Gregory, R. A. and Tracy, H. J. (1964). The constitution and properties of two gastrins extracted from hog antral mucosa. Gut 5, 103-117.

5. Black, J. W., Duncan, W. A. M., Durant, C. J., Ganellin, C. R. and Parsons, E. M. (1972). Definition and antagonism of histamine H2-receptors. Nature 236, 385-390.

6. Marshall, B. J. and Warren, J. R. (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 323, 1311-1315.

7. Guyton, A. C. and Hall, J. E. (2021). Textbook of Medical Physiology (14th ed.). Elsevier.

8. Sherwood, L. (2016). Human Physiology (9th ed.). Cengage.

9. Silverthorn, D. U. (2019). Human Physiology: An Integrated Approach (8th ed.). Pearson.

10. Johnson, L. R. (2020). Gastrointestinal Physiology (9th ed.). Elsevier.

11. Gershon, M. D. (1998). The Second Brain: A Groundbreaking New Understanding of Nervous Disorders of the Stomach and Intestine. HarperCollins.

12. Sanders, K. M., Koh, S. D., Ro, S. and Ward, S. M. (2012). Regulation of gastrointestinal motility -- insights from smooth muscle biology. Nat. Rev. Gastroenterol. Hepatol. 9, 633-645.